Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

注射用核糖核酸Ⅰ - NMPA Drug Approval Details

Approvals/NMPA/Ribonucleic Acid Ⅰ for Injection

Approved

化学药品

Ribonucleic Acid Ⅰ for Injection

威世药业（如皋）有限公司🇨🇳 National Medical Products Administration

Approval Date: Sep 30, 2010
Approval ID: 7zyaHTobO2m
Company: 威世药业（如皋）有限公司
Type: 化学药品

Approval Details

Approval Id: 7zyaHTobO2m
Approval Number: 国药准字H20003847
Generic Name: 注射用核糖核酸Ⅰ
Generic Name En: Ribonucleic Acid Ⅰ for Injection
Drug Type: 化学药品
Strength: 6mg
Reg Date: 2010-09-30
Company Name: 威世药业（如皋）有限公司
Production Company Address: 江苏省如皋市如城普庆路139号
Company Detail Path: /organization/wei-shi-yao-ye-ru-gao-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 30, 2010

Approval ID

7zyaHTobO2m

Type

化学药品

Back to NMPA Approvals